OCUGEN, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OCUGEN, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $612.00K, a 461.47% increase year-over-year.
- OCUGEN, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $409.00K.
- OCUGEN, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $180.00K, a 2.27% increase year-over-year.
- OCUGEN, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $109.00K.
- OCUGEN, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $2.00K, a 66.67% decline from fiscal 2017.
- OCUGEN, INC. stock issued during period, value, stock options exercised for fiscal 2017 was $6.00K, a 100.00% increase from fiscal 2016.
- OCUGEN, INC. stock issued during period, value, stock options exercised for fiscal 2016 was $3.00K, a 92.31% decline from fiscal 2015.
- OCUGEN, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $39.00K, a 50.00% increase from fiscal 2014.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-09-30 | $612.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $409.00K 10-Q · filed 2022-11-08 | |
| 2022-03-31 | $180.00K 10-Q · filed 2022-11-08 | |
| 2021-09-30 | $109.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $176.00K 10-Q · filed 2022-11-08 | |
| 2018-12-31 | $2.00K 10-K · filed 2019-03-22 | |
| 2018-03-31 | $2.00K 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $6.00K 10-K · filed 2019-03-22 | |
| 2016-12-31 | $3.00K 10-K · filed 2018-03-15 | |
| 2015-12-31 | $39.00K 10-K · filed 2017-03-16 | |
| 2014-12-31 | $26.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |